ORPP logo
Image from Google Jackets

Optimization of Research and Clinical Applications for Combat-related Posttraumatic Stress Disorder (PTSD) : Progress Through Modern Translational Methodologies RUSH.

By: Contributor(s): Material type: TextTextSeries: Psychiatry - Theory, Applications and TreatmentsPublisher: Hauppauge : Nova Science Publishers, Incorporated, 2010Copyright date: ©2010Edition: 1st edDescription: 1 online resource (77 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781616683580
Subject(s): Genre/Form: Additional physical formats: Print version:: Optimization of Research and Clinical Applications for Combat-related Posttraumatic Stress Disorder (PTSD): Progress Through Modern Translational MethodologiesDDC classification:
  • 616.85/212
LOC classification:
  • RC552.P67 -- O68 2010eb
Online resources:
Contents:
Intro -- OPTIMIZATION OF RESEARCH AND CLINICAL APPLICATIONS FOR COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD): PROGRESS THROUGH MODERN TRANSLATIONAL METHODOLOGIES -- OPTIMIZATION OF RESEARCH AND CLINICAL APPLICATIONS FOR COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD): PROGRESS THROUGH MODERN TRANSLATIONAL METHODOLOGIES -- CONTENTS -- ABSTRACT -- INTRODUCTION -- PTSD DIAGNOSTIC CRITERIA ANDTREATMENT OBJECTIVES -- FROM THE BENCH: TRANSLATIONAL RESEARCH -- Translational Research: Fear Potentiation and Fear Inhibition -- Translational Research: Conditioned Fear Extinction -- Translational Research: Animal Models of PTSD -- AT THE "BEDSIDE": ADVANCEMENTS INEXPOSURE THERAPY FOR PTSD -- At the "Bedside": Exposure Therapy -- At the "Bedside": Virtual Reality -- AT THE "BEDSIDE": ADVANCEMENTS IN PHARMACOLOGICAL INTERVENTIONS FOR PTSD -- At the "Bedside": Antipsychotics -- Risperidone -- At the "Bedside": Antipsychotics -- Olanzapine -- At the "Bedside": Anticonvulsants -- Valproic Acid -- Lamotrigine -- At the "Bedside": Adrenergic Inhibitors -- Prazosin -- From Bench to "Bedside:" Potential Pharmacotherapies for PTSD -- At the Bench: D-cycloserine (DCS) -- At the "Bedside": D-cycloserine -- Still at the "Bench": Cannabinoid Receptor (CB1) Agonists -- Still at the "Bench": Valproic Acid (VPA) -- From Bench to "Bedside": Pharmacologic Summary -- RISK VERSUS RESILIENCE FOR THE DEVELOPMENTOF PTSD FOLLOWING TRAUMA -- Potential Genetic Vulnerability Risk Factors -- Twin Studies -- Commonly Reported Genetic Variants -- Serotonin (5-HT) Transporter (SERT) -- FKBP5 -- Dopamine Beta-Hydroxylase -- Resilience Factors -- PTSD and Co-morbidity with Major Depressive Disorder: Common Genetic Liability -- Epigenetics -- FUTURE DIRECTIONS -- CONCLUSION -- REFERENCES -- INDEX.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- OPTIMIZATION OF RESEARCH AND CLINICAL APPLICATIONS FOR COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD): PROGRESS THROUGH MODERN TRANSLATIONAL METHODOLOGIES -- OPTIMIZATION OF RESEARCH AND CLINICAL APPLICATIONS FOR COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD): PROGRESS THROUGH MODERN TRANSLATIONAL METHODOLOGIES -- CONTENTS -- ABSTRACT -- INTRODUCTION -- PTSD DIAGNOSTIC CRITERIA ANDTREATMENT OBJECTIVES -- FROM THE BENCH: TRANSLATIONAL RESEARCH -- Translational Research: Fear Potentiation and Fear Inhibition -- Translational Research: Conditioned Fear Extinction -- Translational Research: Animal Models of PTSD -- AT THE "BEDSIDE": ADVANCEMENTS INEXPOSURE THERAPY FOR PTSD -- At the "Bedside": Exposure Therapy -- At the "Bedside": Virtual Reality -- AT THE "BEDSIDE": ADVANCEMENTS IN PHARMACOLOGICAL INTERVENTIONS FOR PTSD -- At the "Bedside": Antipsychotics -- Risperidone -- At the "Bedside": Antipsychotics -- Olanzapine -- At the "Bedside": Anticonvulsants -- Valproic Acid -- Lamotrigine -- At the "Bedside": Adrenergic Inhibitors -- Prazosin -- From Bench to "Bedside:" Potential Pharmacotherapies for PTSD -- At the Bench: D-cycloserine (DCS) -- At the "Bedside": D-cycloserine -- Still at the "Bench": Cannabinoid Receptor (CB1) Agonists -- Still at the "Bench": Valproic Acid (VPA) -- From Bench to "Bedside": Pharmacologic Summary -- RISK VERSUS RESILIENCE FOR THE DEVELOPMENTOF PTSD FOLLOWING TRAUMA -- Potential Genetic Vulnerability Risk Factors -- Twin Studies -- Commonly Reported Genetic Variants -- Serotonin (5-HT) Transporter (SERT) -- FKBP5 -- Dopamine Beta-Hydroxylase -- Resilience Factors -- PTSD and Co-morbidity with Major Depressive Disorder: Common Genetic Liability -- Epigenetics -- FUTURE DIRECTIONS -- CONCLUSION -- REFERENCES -- INDEX.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.